(Photo by Rick Mellerup)
Anne Markel-Crozier, a certified social worker, and Matthew Brasette, an attorney, addressed the crowd at a recent lecture at Stockton University in Manahawkin. Theywere discussing the use of medical marijuana among older adults in New Jersey.
They had plenty to talk about.According to data gathered from the National Survey on Drug Use and Health from 2015 and 2016, about 9 percent of U.S. adults between ages 50 and 64 had used marijuana in the previous year. About 3 percent of people over 65 used pot in that same time period.
In 2013, that same survey showed 7 percent of Americans ages 50 to 64 used marijuana, and only 1.4 percent of people 65 years of age or older had indulged. In fact, seniors are the fastest-growing pot demographic in the country.
Why? Because marijuana, or even CBD products which are required to have less than 0.3 percent THC, the cannabinoid (out of more than 100) in marijuana that gets you high seem to offer a number of health benefits.
Marijuana is widely touted as having beneficial effects on pain, and seniors tend to have more aches and pains than younger people. And marijuana, anecdotally at least, can help with several health conditions.
According to Markel-Crozier, the medical benefits of marijuana include preventing Alzheimers disease, treating glaucoma, relieving arthritis, controlling seizures, easing the pain of multiple sclerosis, soothing tremors from Parkinsons disease, helping with Crohns disease, decreasing anxiety, reducing severe pain and nausea from chemo treatments, and stimulating appetite. It also helps veterans and others suffering from post traumatic stress syndrome.
On the other hand, she said, pot does pose some threats to seniors. It can lead to drowsiness and dizziness, resulting in falls, a huge concern for the elderly population. It can also increase cardiac arrhythmia, decrease blood pressure and affect blood sugar levels.
True, the research remains somewhat limited because marijuana is still listed by the federal government as a Schedule I narcotic that supposedly has no currently accepted medical use and has a high potential for abuse. That puts pot in the same class as heroin, LSD, ecstasy, methaqualone and peyote, and hampers on research.
But medical marijuana use is legal in 33 states, while 11 have legalized recreational use for folks over the age of 21. New Jersey is one of the former and, after a referendum this November, could become one of the latter as well.
New Jersey allows doctors only some doctors, more on that later to recommend pot for Lou Gehrig disease or amyotrophic lateral sclerosis, anxiety, chronic pain related to muscoloskeletal disorders such as fibromyalgia and lupus, chronic pain of visceral origin in other words, pain from internal organs such as the stomach and bladder migraines, MS, terminal cancer, muscular dystrophy, inflammatory bowel disease, Tourette syndrome, seizure disorders including epilepsy, intractable muscular skeletal spasticity, glaucoma, PTSD, positive status for HIV, AIDS and opioid use disorder.
Market-Crozier and Brasette work for the Bratton Law Group, estate and elder care attorneys. Markel-Crozier is the firms director of care coordination. Why were they delivering the lecture? Because getting your hands on medical marijuana in this may be legal, but it certainly isnt easy.
The Process
Is Complicated
First of all, you have to visit a physician who will perform a marijuana evaluation and decide if you warrant a written recommendation. Note it is a recommendation, not a prescription, a difference caused by pots Schedule I status. It is simply a matter, so to say, of legal fine print the written recommendation allows you to legally purchase medical marijuana even though it isnt officially a prescription.
Not all doctors in New Jersey can do that, only the ones registered with the state Department of Health Division of Medicinal Marijuana. Brasette said that as of March 2019, there were almost 1,000 physicians participating in the program, with 48 in Ocean County. Only six, however, have offices in the southern part of the county. They are Paul Chung and Evan Naylor, medical oncologists, and Joseph Lattanzi, a radiation oncologist, in Manahawkin; John Kulin, an emergency medicine doctor with offices in both Little Egg Harbor Township and Manahawkin; Andrew Marino, a family practitioner in Forked River; and another family practitioner, David Rola, in Lanoka Harbor.
The complete list of doctors who are registered with the program can be found on the state Department of Healths Division of Medicinal Marijuana website. According to the DMM, the program now serves over 72,000 patients.
Once you get a doctors recommendation, you must register with the DMM. You can do so on the programs website. It costs most people $100 to register, but only $20 if you are a senior citizen, a military veteran, or qualify for the New Jersey Medicaid program, Supplemental Nutrition Assistance Program (SNAP) benefits, N.J. Temporary Disability Insurance benefits, Supplemental Security Income Benefits or Social Security Disability Benefits. The registration is good for two years.
The next step is to find a licensed medical marijuana dispensary, officially called an alternative treatment center. There are only eight throughout the state and none in Ocean County. However, there are two within a relatively short driving distance, both run by the Compassionate Care Foundation Inc., a.k.a The Botanist. One is located at 100 Century Drive in Egg Harbor Township while the other is a satellite on the Atlantic City Boardwalk, 1301 Boardwalk to be exact. The Boardwalk Botanist shop, situated next to a shoe store, just opened on Feb. 22.
The state Department of Health sought applicants last summer so that it can eventually license up to 24 dispensaries throughout the state.
What You
Can Get
Medical marijuana in New Jersey is packaged in quarter-ounce or eighth-ounce denominations. Just how much you can purchase depends on the amount a registered doctor recommended.
The maximum amount allowed is three ounces in a 30-day period unless the patient is terminal, in which case the amount is unlimited.
The Botanist is currently offering a wide variety of products with exotic names such as Blueberry Kush, Mango, The Messiah, White Widow, Pine Tar, Lemon Skunk, Candy Rain and Fire Alien Romulan. It also sells pre-rolled varieties Jack 22, The Prophet and Citrus Sap.
Confused? Dont worry, The Botanist sales staff is experienced and can easily explain the difference among its offerings.
Seniors, though, could be confused, or even unable to drive to Atlantic County. Dont worry, the state allows qualified patients to designate a primary caregiver who can assist them.
The brands, even with their exotic names, are different, and not only in potency and taste. According to Markel-Crozier, different strains of marijuana can be grown that can be genetically guided to treat specific conditions. In other words, marijuana growers can manipulate and cross-breed the elements of marijuana strains down to very specific functions, such as the ability to treat specific symptoms such as nausea, appetite, etc. Thats because as far back as the 1980s, scientists were able to pinpoint the parts of the brain and body that the main chemicals in marijuana interact with. These spots are called cannabinoid (CB) receptors. These receptors are areas in our body that allow the chemicals to attach to them. The chemicals can cause different responses and positive effects to a variety of symptoms.
One problem with medical marijuana: No health plans, including Medicare, Medicaid or any private health plans, will pay for it.
There are stigmas associated with marijuana use as well. Some seniors whom medical marijuana might help with a wide variety of conditions simply dont want to be known as a pothead. They worry it is a gateway drug. And they worry they could become dependent on pot, although Markel-Crozier said studies show only 9 percent of individuals using cannabis will become dependent. That is, she said, significantly lower than those reported for prescription medications such as opioids and benzodiazepines.
Seniors in assisted living and nursing home facilities have significant problems if they want to use medical marijuana, which is why the Bratton law group has become involved with the issue. Remember, the federal government still considers marijuana and CBD products as well a Schedule I drug with not currently accepted medical use and a high potential for abuse. And assisted living and nursing home facilities, as well as hospitals, receive federal funding via Medicare. States are having a hard time figuring out how to rectify this dilemma. Complicating the issue is that such facilities usually have strict smoking policies.
There are some facilities that will allow residents to use, said Markel-Crozier. But there are plenty of such facilities that wont.
More here:
Seniors Increasingly Turn to Medicinal Marijuana - The SandPaper
- Muscular .Dystrophy -Successful-treatment by acupressure , Ayurveda, Yoga - May 10th, 2011 [May 10th, 2011]
- Muscular Dystrophy Treatment - Todd Harrison Improving Balance - May 16th, 2011 [May 16th, 2011]
- Oculopharyngeal Muscular Dystrophy (OPMD): Exploring Causes and Treatment - May 20th, 2011 [May 20th, 2011]
- Muscular Dystrophy Treatment - Todd Harrison holding body weight - May 21st, 2011 [May 21st, 2011]
- David G VECTTOR Muscular Dystrophy Treatment double arm strength month 6 - May 22nd, 2011 [May 22nd, 2011]
- David Gould Becker Muscular Dystrophy VECTTOR Treatment - June 2nd, 2011 [June 2nd, 2011]
- Muscular Dystrophy Halo - June 3rd, 2011 [June 3rd, 2011]
- Muscular Dystrophy VECTTOR Treatment Documentary - Todd's 6 Month Journey - June 7th, 2011 [June 7th, 2011]
- Muscular Dystrophy Treatment Results - David Gould - New Footage - June 8th, 2011 [June 8th, 2011]
- Muscular Dystrophy - Rewriting History with VECTTOR - June 10th, 2011 [June 10th, 2011]
- Muscular Dystrophy - David Gould 5 month VECTTOR treatment for BMD - June 12th, 2011 [June 12th, 2011]
- Duchenne's Muscular Dystrophy Stem Cell Treatment - Reelabs India - June 14th, 2011 [June 14th, 2011]
- Muscular Dystrophy VECTTOR Treatment - Todd Harrison/Luau Presentation - June 16th, 2011 [June 16th, 2011]
- Dr. William Rader - Muscular Dystrophy Breakthrough - June 16th, 2011 [June 16th, 2011]
- Muscular Dystrophy patient at Xcell-center - Nabeel Mohamed Abdulhusain, 46 years - June 17th, 2011 [June 17th, 2011]
- Charlie's Story: Duchenne Muscular Dystrophy Part 4 - July 18th, 2011 [July 18th, 2011]
- Muscular Dystrophy VECTTOR Treatment - David Gould/Luau Presentation - July 19th, 2011 [July 19th, 2011]
- Testimonial 4 of Muscular Dystrophy after Stem Cell Therapy - August 5th, 2011 [August 5th, 2011]
- Drug Combo Dynamic in Muscular Dystrophy - August 9th, 2011 [August 9th, 2011]
- Testimonial for Fetal Stem Cell Treatment of Duchenne Muscular Dystrophy - August 25th, 2011 [August 25th, 2011]
- Improvement seen in Duchenne Muscular Dystrophy after Stem Cell Therapy - September 11th, 2011 [September 11th, 2011]
- Muscular Dystrophy STS/VECTTOR treatment results - September 24th, 2011 [September 24th, 2011]
- Muscular Dystrophy VECTTOR Treatment Documentary - Todd's One Year Journey - October 2nd, 2011 [October 2nd, 2011]
- Muscular Dystrophy Treatment Day 18 - Todd Harrison's Improvement - October 2nd, 2011 [October 2nd, 2011]
- Wang Yisheng - Muscular Dystrophy Adult Stem Cell Patient - October 9th, 2011 [October 9th, 2011]
- Becker Muscular Dystrophy Miracle TREATMENT - October 11th, 2011 [October 11th, 2011]
- Muscular dystrophy patient_Kleber_Brazil.wmv - October 12th, 2011 [October 12th, 2011]
- Testimonial 1 of Muscular Dystrophy after Stem Cell Therapy - Video - October 18th, 2011 [October 18th, 2011]
- Becker Muscular Dystrophy STS Treatment - Video - October 18th, 2011 [October 18th, 2011]
- Potential Stem Cell treatment of Duchenne Muscular Dystrophy - Video - October 21st, 2011 [October 21st, 2011]
- Muscular Dystrophy treated by Dr Rajesh Shah at Life Force - Video - October 22nd, 2011 [October 22nd, 2011]
- Defying Muscular Dystrophy - I Made It - Video - October 23rd, 2011 [October 23rd, 2011]
- Becker Muscular Dystrophy AMAZING treatment results - Video - October 27th, 2011 [October 27th, 2011]
- First targeted treatment success for Duchenne muscular dystrophy - Video - November 6th, 2011 [November 6th, 2011]
- 125 Days of VECTTOR Treatment Progress - November 18th, 2011 [November 18th, 2011]
- Becker Muscular Dystrophy WALKING ABILITY IMPROVED - Video - November 25th, 2011 [November 25th, 2011]
- PT Muscular Dystrophy Treatment Results - Video - December 5th, 2011 [December 5th, 2011]
- Duchenne Muscular Dystrophy Treated by Cellmedicine - Video - January 8th, 2012 [January 8th, 2012]
- muscular DYSTROPHY treatment IN HOMEOPATH.mp4 - Video - January 28th, 2012 [January 28th, 2012]
- Giulio's strategy is to cure dystrophy with stem cell treatment - Video - January 31st, 2012 [January 31st, 2012]
- Parent Project Muscular Dystrophy is a Featured Nonprofit Selected by Webkinz(TM) Foundation - February 1st, 2012 [February 1st, 2012]
- MDA Awards More Than $12 Million in Grants to Advance Neuromuscular Disease Research - February 1st, 2012 [February 1st, 2012]
- "For treatment we will have in the future" - Video - February 2nd, 2012 [February 2nd, 2012]
- Renowned Pediatric Cardiology Physician-Scientist Linda Cripe Joins Nationwide Children's Hospital - February 3rd, 2012 [February 3rd, 2012]
- JumpStart Invests $250,000 in Milo Biotechnology - February 14th, 2012 [February 14th, 2012]
- When nerve meets muscle, biglycan seals the deal - February 14th, 2012 [February 14th, 2012]
- Medical clinics offer help for Big Island children - February 16th, 2012 [February 16th, 2012]
- Dateline Long Beach: The Aquatic Center brings swim therapy to disabled - February 19th, 2012 [February 19th, 2012]
- Parent Project Muscular Dystrophy Awards $500,000 to Tivorsan Pharmaceuticals - February 21st, 2012 [February 21st, 2012]
- Cure Duchenne Announces Three New Funded Research Projects to Help Develop Treatments and Find a Cure for Duchenne ... - February 21st, 2012 [February 21st, 2012]
- Ligand Licenses DARA Program to Retrophin - February 21st, 2012 [February 21st, 2012]
- AVI BioPharma Regains NASDAQ Compliance - February 23rd, 2012 [February 23rd, 2012]
- Scientists create potent molecules aimed at treating muscular dystrophy - February 23rd, 2012 [February 23rd, 2012]
- AVI BioPharma Announces Fourth Quarter and Full Year 2011 Financial Results and Corporate Update Conference Call - February 23rd, 2012 [February 23rd, 2012]
- Pembroke's Christine McSherry is an 'Inspirational Woman' - February 25th, 2012 [February 25th, 2012]
- The Rare Clinical Diseases Research Network - February 25th, 2012 [February 25th, 2012]
- A Solution for Duchenne Muscular Dystrophy? - Research Summary - February 28th, 2012 [February 28th, 2012]
- A Solution for Duchenne Muscular Dystrophy? -- In Depth Doctor's Interview - February 28th, 2012 [February 28th, 2012]
- Antisense oligonucleotides make sense in myotonic dystrophy - February 28th, 2012 [February 28th, 2012]
- A life of dependence - February 29th, 2012 [February 29th, 2012]
- Nationwide Children's Hospital neuromuscular disorder podcasts now available on iTunes - March 2nd, 2012 [March 2nd, 2012]
- Next-generation DNA sequencing to improve diagnosis for muscular dystrophy - March 6th, 2012 [March 6th, 2012]
- The Dire Limits of Health Care - March 7th, 2012 [March 7th, 2012]
- AVI BioPharma Announces Late-Breaker Oral Presentation of Phase IIb DMD Study at 2012 AAN Annual Meeting in April - March 12th, 2012 [March 12th, 2012]
- Cataracts affect millions of people around the globe, and for many of us they will be a normal part of our aging ... - March 14th, 2012 [March 14th, 2012]
- Your Health: Duchenne's Muscular Dystrophy - March 16th, 2012 [March 16th, 2012]
- Newborn Screening for Duchenne Muscular Dystrophy Shows Promise as an International Model - March 20th, 2012 [March 20th, 2012]
- Newborn screening for DMD shows promise as an international model - March 20th, 2012 [March 20th, 2012]
- Rhenovia launches drug discovery for Huntington's disease - March 20th, 2012 [March 20th, 2012]
- Halo Therapeutics Reports Favorable Independent Review of Lead Drug Candidate HT-100 - March 21st, 2012 [March 21st, 2012]
- Invasive treatment strategy may increase survival for patients with certain neuromuscular disorder - March 28th, 2012 [March 28th, 2012]
- Parent Project Muscular Dystrophy Endorses FAST Act Legislation to Expedite FDA Review of Life-Saving Therapies - March 29th, 2012 [March 29th, 2012]
- AVI BioPharma Announces Conference Call and Webcast on Monday, April 2, 2012, to Discuss Top-Line Data Results From ... - March 31st, 2012 [March 31st, 2012]
- Drug for rare disease may lift AVI BioPharma shares: Barron's - April 2nd, 2012 [April 2nd, 2012]
- AVI BioPharma Announces Eteplirsen Meets Primary Endpoint, Demonstrating a Significant Increase in Dystrophin at 24 ... - April 2nd, 2012 [April 2nd, 2012]
- U.S. Stock Futures Little Changed Before Factory Report - April 2nd, 2012 [April 2nd, 2012]
- Leading experts on congenital muscular dystrophy convene at University of Nevada, Reno - April 20th, 2012 [April 20th, 2012]
- Nature Publishes Work Utilizing N-Gene's Core Technology to Advance the Treatment of Duchenne Muscular Dystrophy - April 20th, 2012 [April 20th, 2012]
- Getting the boots filled - April 29th, 2012 [April 29th, 2012]
- Local business, civic leaders 'arrested' for MDA fundraiser - May 3rd, 2012 [May 3rd, 2012]